Pharma & Life Sciences
GxP decisions that survive inspection months later.
No Stamp → No Ship for high-impact GxP decisions.
Inspections and partner audits don't judge your QMS. They judge what you can prove was authorised, within scope, at decision time — and whether reliance stops when conditions change.
- Gate high-impact actions by Status Link: not VALID → block or escalate (per programme SOP)
- Proof that travels outside your perimeter: counterparties verify scope • expiry • signer • status by link
- Evidence Pack (IDA format) (decision-time snapshot): reusable across inspections, audits, and partner reviews
Fail-closed•Append-only•Scope-bounded
Not a certification. Scope-limited verification. Acceptance depends on counterparty/programme requirements.
Why pharma buyers are moving now
Inspection pressure, AI governance shifts, and data-integrity risk are converging.
Inspection and partner audit pressure
Decisions are challenged months later. Teams need portable proof of what was authorised, within scope, at decision time.
AI governance is moving into GxP
Regulatory direction is pushing for traceability and controllability in AI-assisted lifecycle decisions.
Data integrity remains a live risk
Integrity failures still trigger findings and remediation; narrative-only evidence is fragile under scrutiny.
Cross-company reliance is hard
Sponsor, CDMO, CRO, and supplier ecosystems need verifiable-by-link status without exposing internal systems.
Good Proof provides scope-limited verification evidence and stop-rely semantics. It is not a certification.
What a Stamp proves (and what it doesn't)
Proves (within lane scope)
- Decision class + outcome (batch disposition, CAPA closure, change approval, PV triage/escalation, supplier qualification)
- Decision-time timestamp
- Signer/authority reference
- Scope boundary + expiry window
- Validity state (VALID / NEEDS REFRESH / WITHDRAWN / NOT VERIFIED)
- Evidence window for inspection/audit/dispute
Does NOT prove
- Product quality truth or clinical correctness
- System validation / CSV / CSA completion
- Certification or regulatory compliance
- Raw batch/PV/PII payloads by default
In inspections: Status Link = reliance state now. Evidence Pack = fileable decision-time record bundle.
Not a certification. Scope-limited verification. Acceptance depends on counterparty/programme requirements.
Integration in 3 touchpoints
1
Issue
At decision issuance (batch release exception, CAPA closure, change approval, PV escalation) → require Stamp
2
Communicate
In QMS record / audit packet / partner notification → include Status Link
3
Rely
At ship / release / close / implement change → verify Status Link (fail-closed)
High-impact gating only. Everything else runs normally.
Global Coverage
Regulatory reality
No hype, no compliance claims — portable proof that survives cross-border review.
US
Lifecycle governance and audit expectations; defensible records for high-impact decisions
EU
Lifecycle AI governance direction for medicinal product lifecycle; inspection readiness expectations
UK
Governance and inspection expectations; supplier/quality record defensibility
Canada
Governance expectations for AI and regulated operations; defensible record-keeping
Australia
Governance expectations for AI and regulated operations; defensible record-keeping
Asia
Governance frameworks emphasize traceability/controllability/bounded risk
Middle East
Pharmaceutical governance and quality expectations expanding; defensible records for lifecycle decisions
Africa
Medicines regulation strengthening across regional bodies; portable verification supports cross-border reliance
Good Proof doesn't certify compliance. It makes outputs verifiable, refreshable, withdrawable by link — so your SOPs and records survive scrutiny.
Jurisdictional Configuration
Country overlays can be configured per programme
Examples include programme-specific mapping for Japan, APAC, and other jurisdictions where disclosure, retention, appeal handling, language support, and verifier-access requirements differ.
Not legal advice. Final legal mapping is owned by programme counsel.
Why this sector is painful
Pharma is inspected, audited, and partner-reviewed — repeatedly.
AI is now influencing decisions inside QMS, PV workflows, and clinical operations where the real failure mode is not "the model was wrong."
It's: we can't prove what was true at decision time — and what's valid now — without exporting half the system.
What gets stamped in Pharma
Examples of high-impact action classes (define per programme):
GMP and Quality
- Batch release exceptions and disposition decisions
- Deviations and CAPA closure decisions
- Change control approvals that affect validated state
- OOS/OOT triage outcomes when escalation is required
- Supplier qualification or disqualification decisions
Clinical
- Eligibility and screening overrides
- Protocol deviation classification and closure
- Randomization or stratification exceptions (where applicable)
- Site risk actions that affect patient participation
Safety (PV)
- Seriousness and expectedness classification outcomes
- Signal triage decisions that trigger action
- Case follow-up closure when challenged
- Recall or safety communication triggers (programme scoped)
Patient access and support
- Access eligibility determinations
- Hardship or exception approvals
- Appeals outcomes that must be defensible
What you get (two artefacts, one standard)
Status Link (authoritative now)
A counterparty-verifiable link that returns current validity within scope.
- Returns: status, scope, expiry, verified_at, signer, verify_url
- Fail-closed: unreachable = NOT_VERIFIED
- Built for SOPs, QMS workflows, tickets, and automated gates
IDA Evidence Pack (snapshot then)
View full details →A time-stamped snapshot you can forward, file, and cite.
- Built for inspections, audits, disputes, and procurement
- Minimal disclosure by default (proof ≠ payloads)
- Programme-configured redaction matrix
PDFs are great for filing. Status Links keep them current.
When status changes — and what it means
Status triggers define when a Status Link moves to NEEDS_REFRESH or WITHDRAWN. Understanding these ensures fail-closed enforcement at inspection time.
NEEDS_REFRESH
When any of these occur, re-verify before you rely.
SOP/policy version change affecting decision class
Model/tool version or configuration change
Supplier qualification status change
Validation boundary or CSV/CSA scope change
Incident raised on the lane → pending review
NEEDS_REFRESH means "re-verify before you rely," not "schedule a meeting."
WITHDRAWN
Stop-rely signal. Action must not proceed.
Confirmed data integrity breach affecting decision
Validation/qualification scope invalidated
Recall or safety signal requiring stop-rely
Material misstatement discovered post-approval
Incident outcome requires immediate stop-rely
Fail-closed: Wherever the Status Link is checked, if WITHDRAWN → block or escalate.
What's inside the IDA Evidence Pack
Decision-time snapshot for inspection, audit, and filing.
Decision summary + lane scope boundary
Decision-time timestamp + evidence window
SOP/policy identifier + version references (where applicable)
Workflow/tool surface identifier + version references
Signer/authority reference
Verification transcript + timestamps
Redaction matrix (what is intentionally excluded)
Minimal disclosure by default. Programme-scoped if required, with auditable access trails.
Who buys this in Pharma & Life Sciences
Commercial and public-sector buyers with high-impact decision accountability.
Commercial buyers
QA / Quality Systems
Pain: Inspection findings challenge what was authorised and when.
Outcome: Status Link + Evidence Pack prove decision scope, signer, and validity at decision time.
Book a Pharma Stamp SprintPV Safety Operations
Pain: Triage and escalation decisions face retrospective scrutiny.
Outcome: Append-only verification history with fail-closed reliance control for safety signals.
Book a Pharma Stamp SprintSupplier Quality + External Manufacturing
Pain: Supplier changes silently invalidate prior qualifications.
Outcome: Material change triggers NEEDS REFRESH; stop-rely on WITHDRAWN propagates wherever checked.
Book a Pharma Stamp SprintClinical Quality / GCP Oversight
Pain: Protocol deviations and site actions are hard to defend without decision-time records.
Outcome: Scoped verification for deviation classification, eligibility overrides, and site risk actions.
Book a Pharma Stamp SprintRegulatory Affairs Operations
Pain: Submission and lifecycle decisions lack portable verification outside internal systems.
Outcome: Counterparty-verifiable status with scope boundaries and configurable evidence windows.
Book a Pharma Stamp SprintGxP IT / Validation / Digital Quality
Pain: Adding controls often means system replacement risk and validation overhead.
Outcome: Lane-scoped gate check at issuance, notification, and reliance points; no rip-and-replace.
Book a Pharma Stamp SprintInternal Audit / Inspection Readiness
Pain: Evidence retrieval for inspections is slow and system-bound.
Outcome: Fileable Evidence Pack snapshots with append-only history and redaction matrix.
Book a Pharma Stamp SprintLegal + Procurement
Pain: Contract clauses lack machine-checkable verification semantics.
Outcome: Procurement-ready clause template + Schedule A with status-linked operating rules.
Book a Pharma Stamp SprintPublic-sector and quasi-public buyers
National medicines regulators / inspectorates
Pain: Control testing depends on system-bound evidence and inconsistent logs.
Outcome: Verifier-checkable status with portable Evidence Pack for cross-border review.
Book a Pharma Stamp SprintPublic health pharmacovigilance programmes
Pain: Safety signal escalation workflows lack portable decision-time proof.
Outcome: Scoped verification for triage, escalation, and signal actions with fail-closed semantics.
Book a Pharma Stamp SprintPublic hospital networks / central pharmacy authorities
Pain: Formulary and procurement decisions are challenged across agencies.
Outcome: Status-linked governance evidence with configurable redaction and retention.
Book a Pharma Stamp SprintNational blood/transfusion services
Pain: Release and disposition decisions face multi-agency scrutiny.
Outcome: Scope-bounded verification with withdrawal propagation for safety-critical lanes.
Book a Pharma Stamp SprintVaccine programme authorities
Pain: Eligibility, distribution, and recall decisions need defensible records across partners.
Outcome: Portable verification surface for cross-party reliance with stop-rely controls.
Book a Pharma Stamp SprintState procurement and medicine supply authorities
Pain: Supplier qualification evidence is fragile under public audit and FOI scrutiny.
Outcome: Minimal-disclosure evidence model with role-appropriate verifier views.
Book a Pharma Stamp SprintWhere budget comes from
Usually funded from existing risk and compliance lines, not new category spend.
QA/Compliance budget
Trigger: Inspection finding, remediation programme, or recurring CAPA friction
Why it fits: Portable evidence + fail-closed reliance control reduce reconstruction effort and repeat findings.
PV operations budget
Trigger: Signal escalation challenge, case follow-up dispute, or partner audit
Why it fits: Decision-time snapshot + live status make triage and escalation outcomes defensible.
Digital quality/validation budget
Trigger: New tool adoption, AI governance mandate, or validated-state change control
Why it fits: Lane-scoped integration at gate points; minimal validation footprint.
Supplier quality budget
Trigger: Qualification/disqualification challenge, material change notification, or supply disruption
Why it fits: Status-linked supplier decisions with withdrawal propagation and verifier access.
Audit/remediation budget
Trigger: Post-inspection remediation, consent decree work, or internal controls programme
Why it fits: Append-only verification history with Evidence Pack snapshots for review workflows.
Start with one high-impact lane and prove inspection/audit friction reduction before expansion.
Public-sector fit
Useful where medicines decisions require defensible records across agencies, vendors, and review bodies.
Public procurement and release governance
Scope-bounded verification for formulary, release, and disposition decisions across public supply chains.
National safety signal escalation workflows
Fail-closed reliance control for triage and escalation decisions with portable Evidence Pack for cross-agency review.
Cross-agency inspection and review workflows
Verifier-checkable status that travels outside internal portals for multi-agency scrutiny.
Vaccine/biologics programme decision controls
Status-linked governance for eligibility, distribution, recall, and exception decisions with withdrawal propagation.
Programme counsel defines jurisdictional mapping, retention, and disclosure boundaries.
Pharma lane menu
Start with one lane. Prove it in 30 days. Expand when counterparties rely on the Status Link.
What ships every time: Status Link (authoritative now) + Evidence Pack (snapshot then).PDFs are great for filing. Status Links keep them current.
GMP Batch Release + Disposition
Make exception release, disposition, and escalation outcomes inspection-ready with scope + expiry + refresh/withdraw triggers.
Book a Pharma Stamp SprintDeviations + CAPA Closure
Turn closure decisions into portable proof that survives audits, supplier scrutiny, and inspection questions.
Book a Pharma Stamp SprintValidated Change Control
Stamp what's approved (scope, version, boundary) so any material change flips status to NEEDS REFRESH until re-verified.
Book a Pharma Stamp SprintPV Triage + Signal Escalation
Make triage, seriousness/expectedness, and escalation decisions defensible when they're challenged later.
Book a Pharma Stamp SprintSupplier Qualification + Material Changes
Make supplier qualification, disqualification, and material change notifications verifiable and audit-ready.
Book a Pharma Stamp SprintHow it works (simple)
1
Define the high-impact decision class
Scope boundaries, evidence window, and what triggers refresh or withdrawal.
2
Require a Stamp
No Stamp, NOT VERIFIED, or NEEDS REFRESH → block or escalate (per programme SOP).
3
Ship portable proof
Issue the Status Link and generate the Evidence Pack automatically.
4
Humans step in only when required
Guardians handle exceptions and disputes inside defined scope, with anti-rubber-stamp controls.
What counterparties can verify without logging into your perimeter
Current validity state: VALID / NEEDS REFRESH / WITHDRAWN / NOT VERIFIED
Scope boundaries and expiry window
Signer authority reference (system or Guardian panel when required)
Change triggers fired (refresh reason code) — without exposing payloads
Verification route and optional signed verify response (programme scoped)
AI-Agent Era
AI-agent era controls
Prompts can drift. Reliance controls must not.
Material change in SOP/tool/vendor/configNEEDS_REFRESH
Integrity or boundary breachWITHDRAWN
Timeout/unreachable verification routeNOT_VERIFIED (fail-closed)
Exception lane requiring human finalityGuardian path (optional)
Good Proof does not decide outcomes; it controls whether high-impact actions are safe to rely on.
A Global Human Layer
Our Mind Chill Guardian Story
A global human layer that software can't fake.
When liability lands on a person, the sign-off should too.
Conflict-checked · Rotation-based · Audit-traceable · Programme-scoped
When Guardians are used (only when required)
Most decisions remain automated. Humans step in only where human finality is required: exception approvals, disputes, high-risk overrides, or post-incident outcomes with human liability.
Mind Chill Guardians provide programme-scoped human finality for exception lanes only, minimizing sensitive payload handling, with anti-rubber-stamp controls: conflict checks, rotation, sampling audits, and multi-review thresholds for high-risk lanes.
From calming minds to defending outcomes
Mind Chill began in 2017 as immersive art built to reduce anxiety and create calm at scale. Then the same feeds that buried calm and rewarded outrage started training the systems that now make real decisions. We didn't want more rhetoric. We wanted receipts.
The moment it clicked
A message arrived: someone's child felt safer because of what they experienced. Around the same time, lived experience inside our own community made one thing obvious: the nuance that matters in high-impact decisions can't be reliably reduced to a prompt. So we designed a human layer for the edge cases—structured, scope-bound, and auditable.
Guardians are not a "panel." They're a network.
Mind Chill Guardians come from different countries, backgrounds, and lived realities. That diversity is not branding—it's risk reduction. It makes decisions harder to game, easier to challenge, and more credible under scrutiny. Guardians do not "run the system." They review only what the lane requires humans to own.
Receipts over rhetoric
Operational Guardians plug into Good Proof lanes as a controlled finality mechanism: conflict checks, rotation, multi-review where required, and an audit trace tied to a Status Link. Minimal disclosure by default. If a decision is appealed months later, you can show what happened, within scope, without dumping sensitive payloads.
Why buyers choose Guardians
Lived experience at the edge cases (not a generic helpdesk)
Conflict-checked + rotation-based (anti-rubber-stamp by design)
Multi-review on high-risk lanes (when the programme requires it)
Audit-traceable outcomes (defensible in inspections, audits, procurement)
Minimal disclosure by default (proof, not payloads)
Not a certification. Scope-limited verification. Acceptance depends on counterparty/programme requirements.
Procurement-ready clause
Template language for your legal team.
"For [High-Impact Decision Classes], Supplier shall issue a Good Proof Stamp prior to action. Buyer may verify status via the Status Link. Stamps returning NOT VERIFIED, NEEDS REFRESH, or WITHDRAWN shall block or escalate per programme SOP."
Schedule A (template — programme terms)
Definitions + operating rules procurement teams can copy/paste.
1. Definitions
- High-Impact Decision Class: a decision type designated for Stamp gating (e.g., batch disposition exception, CAPA closure, change approval).
- Status Link: the verification endpoint returning validity state + scope boundaries.
- Evidence Window: the time period during which supporting materials are retained for inspection.
- Evidence Pack: time-stamped snapshot for filing/disputes (IDA format).
- Scope Boundary: the defined limits of what a Stamp covers (decision class, expiry, programme).
2. Required states
- VALID→ may proceed within scope.
- NEEDS_REFRESH/ NOT_VERIFIED / WITHDRAWN → must block or escalate per lane rules.
- Fail-closed:timeout/unreachable ⇒ NOT_VERIFIED.
3. Withdrawal / stop-rely semantics
- WITHDRAWN is returned wherever the Status Link is checked.
- No execution may proceed on WITHDRAWN.
- Optional: programme hooks/notifications for stop-rely distribution.
SLA placeholders (complete per programme)
Verifier availability target: [___]%. Response-time target: [___] ms. Support turnaround: [___] hours.
Not legal advice. Bracketed variables to be completed by the parties.
Procurement pack available: architecture summary, data handling overview, subprocessors, retention options.
What you get in 30 days
One decision class, production-ready controls.
Lane definition (scope + evidence window + triggers)
Stamp issuance gate integrated
External verification route tested
Refresh/withdraw triggers configured
One redacted IDA specimen generated
SOP insert + verifier checklist
Due Diligence FAQs
Make high-impact pharma decisions shippable.
Not a certification. Scope-limited verification. Acceptance depends on counterparty or programme requirements.